Literature DB >> 19954472

An overview of regular dialysis treatment in Japan (as of 31 December 2007).

Shigeru Nakai1, Ikuto Masakane, Takashi Shigematsu, Takayuki Hamano, Kunihiro Yamagata, Yuuzou Watanabe, Noritomo Itami, Satoshi Ogata, Naoki Kimata, Toshio Shinoda, Tetsuo Syouji, Kazuyuki Suzuki, Masatomo Taniguchi, Kenji Tsuchida, Hidetomo Nakamoto, Shinichi Nishi, Hiroshi Nishi, Seiji Hashimoto, Takeshi Hasegawa, Norio Hanafusa, Naohiko Fujii, Seiji Marubayashi, Osamu Morita, Kenji Wakai, Atsushi Wada, Kunitoshi Iseki, Yoshiharu Tsubakihara.   

Abstract

A nationwide statistical survey of 4098 dialysis facilities was conducted at the end of 2007, and 4052 facilities (98.88%) participated. The number of patients undergoing dialysis at the end of 2007 was determined to be 275 242, an increase of 10 769 patients (4.1%) compared with that at the end of 2006.The number of dialysis patients per million at the end of 2007 was 2154. The crude death rate of dialysis patients at the end of 2007 from the end of 2006 was 9.4%. The mean age of new patients begun on dialysis was 66.8 years and the mean age of the entire dialysis patient population was 64.9 years. For the primary diseases of new patients begun on dialysis, the percentages of patients with diabetic nephropathy and chronic glomerulonephritis were 43.4% and 23.8%, respectively. The percentages of facilities that achieved the control standard of endotoxin concentration in the dialysate solution of <0.05 EU/mL and those that achieved a bacterial count of <100 cfu/mL in the dialysate solution, as specified by the Japanese Society for Dialysis Therapy, were 93.6% and 97.4%, respectively. The percentage of patients positive for the hepatitis C virus antibody among the entire dialysis population significantly decreased from 15.95% at the end of 1999 to 9.83% at the end of 2007. The mean hemoglobin concentration in all the dialysis patients at the end of 2007 was 10.27 (+/-1.32, SD) g/dL, which has scarcely changed over the last three years. The numbers of male and female patients with a history of hip fracture were 142.9 and 339.0 per 10 000 dialysis patients, respectively, showing an extremely high prevalence among female patients. A history of hip fracture correlates with a low body mass index, serum albumin concentration, and a history of diabetes. The serum creatinine level of patients upon introduction to dialysis was 8.34 (+/-3.55) mg/dL, and the estimated glomerular filtration rate was 5.43 (+/-3.43) mL/min/1.73 m(2) for the patients who were newly begun on dialysis in 2007.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19954472     DOI: 10.1111/j.1744-9987.2009.00789.x

Source DB:  PubMed          Journal:  Ther Apher Dial        ISSN: 1744-9979            Impact factor:   1.762


  23 in total

1.  Elevated non-high-density lipoprotein cholesterol (non-HDL-C) predicts atherosclerotic cardiovascular events in hemodialysis patients.

Authors:  Tetsuo Shoji; Ikuto Masakane; Yuzo Watanabe; Kunitoshi Iseki; Yoshiharu Tsubakihara
Journal:  Clin J Am Soc Nephrol       Date:  2011-04-21       Impact factor: 8.237

2.  Decreases in PTH in Japanese hemodialysis patients with secondary hyperparathyroidism: associations with changing practice patterns.

Authors:  Tadao Akizawa; Ryo Kido; Masafumi Fukagawa; Yoshihiro Onishi; Takuhiro Yamaguchi; Takeshi Hasegawa; Shunichi Fukuhara; Kiyoshi Kurokawa
Journal:  Clin J Am Soc Nephrol       Date:  2011-08-11       Impact factor: 8.237

3.  Effectiveness of oral iron to manage anemia in long-term hemodialysis patients with the use of ultrapure dialysate.

Authors:  Akiyasu Tsuchida; Bishnuhari Paudyal; Pramila Paudyal; Yoshitaka Ishii; Keiju Hiromura; Yoshihisa Nojima; Minoru Komai
Journal:  Exp Ther Med       Date:  2010-07-20       Impact factor: 2.447

4.  Chronic kidney disease prevention--a challenge for Asian countries: report of the Third Asian Forum of Chronic Kidney Disease Initiatives.

Authors:  Jer-Ming Chang; Shang-Jyh Hwang; Yusuke Tsukamoto; Hung-Chun Chen
Journal:  Clin Exp Nephrol       Date:  2012-03-03       Impact factor: 2.801

5.  Impact of diabetes and glycaemic control on peripheral artery disease in Japanese patients with end-stage renal disease: long-term follow-up study from the beginning of haemodialysis.

Authors:  H Ishii; Y Kumada; H Takahashi; T Toriyama; T Aoyama; M Tanaka; D Yoshikawa; M Hayashi; H Kasuga; Y Yasuda; S Maruyama; T Matsubara; S Matsuo; T Murohara
Journal:  Diabetologia       Date:  2012-05       Impact factor: 10.122

6.  Efficacy of paclitaxel-eluting stent implantation in hemodialysis patients.

Authors:  Michiaki Higashitani; Fumiaki Mori; Norihiro Yamada; Hiroyuki Arashi; Asako Kojika; Hiromi Hoshi; Yuichiro Minami; Junichi Yamaguchi; Takao Yamauchi; Atsushi Takagi; Hiroshi Ogawa; Nobuhisa Hagiwara
Journal:  Heart Vessels       Date:  2011-01-26       Impact factor: 2.037

7.  Clinical efficacy and cost-effectiveness of lanthanum carbonate as second-line therapy in hemodialysis patients in Japan.

Authors:  Shunsuke Goto; Hirotaka Komaba; Kensuke Moriwaki; Akira Fujimori; Koji Shibuya; Masato Nishioka; Jong-Il Kim; Kunihiko Yoshiya; Jeongsoo Shin; Hirohito Hasegawa; Masatomo Taniguchi; Hideki Fujii; Shinichi Nishi; Isao Kamae; Masafumi Fukagawa
Journal:  Clin J Am Soc Nephrol       Date:  2011-05-05       Impact factor: 8.237

Review 8.  Role of chronic kidney disease in cardiovascular disease: are we different from others?

Authors:  Kunitoshi Iseki
Journal:  Clin Exp Nephrol       Date:  2011-04-05       Impact factor: 2.801

Review 9.  Pathogenesis and therapeutic implications of cardiorenal syndrome.

Authors:  Kosaku Nitta
Journal:  Clin Exp Nephrol       Date:  2010-11-23       Impact factor: 2.801

10.  Japan Diabetic Nephropathy Cohort Study: study design, methods, and implementation.

Authors:  Kengo Furuichi; Miho Shimizu; Tadashi Toyama; Daisuke Koya; Yoshitaka Koshino; Hideharu Abe; Kiyoshi Mori; Hiroaki Satoh; Masahito Imanishi; Masayuki Iwano; Hiroyuki Yamauchi; Eiji Kusano; Shouichi Fujimoto; Yoshiki Suzuki; Seiya Okuda; Kiyoki Kitagawa; Yasunori Iwata; Shuichi Kaneko; Shinichi Nishi; Hitoshi Yokoyama; Yoshihiko Ueda; Masakazu Haneda; Hirofumi Makino; Takashi Wada
Journal:  Clin Exp Nephrol       Date:  2013-02-28       Impact factor: 2.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.